Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
12 December, 2018 21:32 IST
CARE Ratings upgrades Manappuram Finance to AA stable
Source: IRIS | 14 Aug, 2017, 03.49PM
Comments  |  Post Comment

CARE Ratings has upgraded the long-term credit rating of Manappuram Finance (MAFIL) to CARE AA (double A) stable from CARE AA- (double A minus) stable. The revised credit rating applies to the Rs. 56.80 billion long term bank facilities of the company and its NCD issues aggregating to Rs 5.80 billion.

A  press release issued by CARE Ratings said that the revision in the long term rating factors in the significant improvement in financial performance of the company during FY17, primarily supported by its focus on shorter tenure loans leading to lesser under recovery. The profitability in FY17 is also aided by growth in AUM and decline in the cost of borrowings in trend with industry.

The release noted the long track record and the established market position of MAFIL as one of the leading players in the gold loan industry in India, experienced promoters & management team, comfortable capitalization level and liquidity position and adequate risk management & management information systems in place. 

The ratings are, however, constrained by product concentration on a single asset class, exposure to price of gold, geographical concentration of the loan portfolio and moderation in asset quality during FY17 on account of transition from 120 dpd (days past due) to 90 dpd.

Earlier, on July 14, 2017, Brickwork Ratings had upgraded the long-term credit rating of Manappuram (Q,N,C,F)* Finance (MAFIL) to BWR AA (double A) stable from BWR AA- (double A minus) stable. The revised credit rating applies to the Rs 547.0 million NCD issue of the company.

Shares of the company gained Rs 2.95, or 3.44%, to trade at  Rs 88.80.  The total volume of shares traded  was  739,382 at the BSE (3.34 p.m., Monday).



Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Ashok Leyland signs defence agreement with ELBIT Systems - 12-Dec-2018 09:41
Wipro launches automotive innovation center in Michigan - 12-Dec-2018 09:37
Liva Pharmaceuticals gets USFDA approval for its sANDA - Ranitidine Injection - 12-Dec-2018 09:35
Dr Reddy's Labs launches Omeprazole tablets in US market - 12-Dec-2018 09:31
Strides Vivimed JV receives consent for Albendazole tablets - 12-Dec-2018 09:27
Unichem Lab gets tentative nod for Tadalafil tablets - 12-Dec-2018 09:25
Zydus Wellness gets CCI approval for acquisition of Heinz India - 12-Dec-2018 09:20
Wipro Digital to expand Asia Pacific design capabilities in Australia - 11-Dec-2018 09:26
Wipro Digital to expand Asia Pacific design capabilities in Australia - 11-Dec-2018 09:24
Lupin receives tentative USFDA approval for Apixaban tablets - 11-Dec-2018 09:20
Lupin receives EIR from USFDA for Indore facility - 10-Dec-2018 16:10
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer